Atlas Venture Life Science Advisors as of March 31, 2023
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 16 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kymera Therapeutics Common Stock (KYMR) | 23.5 | $174M | 5.9M | 29.63 | |
| Dyne Therapeutics Common Stock (DYN) | 15.4 | $114M | 9.9M | 11.52 | |
| Day One Biopharmaceuticals Common Stock (DAWN) | 13.8 | $102M | 7.6M | 13.37 | |
| Disc Medicine Common Stock (IRON) | 9.9 | $73M | 3.5M | 21.19 | |
| Vigil Neuroscience Common Stock (VIGL) | 7.7 | $57M | 5.8M | 9.79 | |
| Third Harmonic Bio Common Stock (THRD) | 6.1 | $45M | 11M | 4.12 | |
| Aerovate Therapeutics Common Stock (AVTE) | 5.6 | $41M | 2.0M | 20.17 | |
| Replimune Group Common Stock (REPL) | 5.0 | $37M | 2.1M | 17.66 | |
| Generation Bio Common Stock | 4.8 | $36M | 8.3M | 4.30 | |
| Akero Therapeutics Common Stock (AKRO) | 3.1 | $23M | 594k | 38.26 | |
| Ikena Oncology Common Stock (IKNA) | 2.3 | $17M | 5.0M | 3.45 | |
| Xilio Therapeutics Common Stock | 1.2 | $8.7M | 2.8M | 3.17 | |
| AvroBio Common Stock (AVRO) | 0.6 | $4.5M | 4.5M | 1.00 | |
| Magenta Therapeutics Common Stock | 0.4 | $3.0M | 3.8M | 0.79 | |
| Viridian Therapeutics Common Stock (VRDN) | 0.3 | $2.3M | 90k | 25.44 | |
| Spero Therapeutics Common Stock (SPRO) | 0.2 | $1.5M | 1.0M | 1.45 |
